- Home
- ESCA vs CLYM Comparison
ESCA vs CLYM Comparison
Compare ESCA & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESCA
- CLYM
- Stock Information
- Founded
- ESCA 1922
- CLYM 2018
- Country
- ESCA United States
- CLYM United States
- Employees
- ESCA N/A
- CLYM N/A
- Industry
- ESCA Recreational Games/Products/Toys
- CLYM
- Sector
- ESCA Consumer Discretionary
- CLYM
- Exchange
- ESCA Nasdaq
- CLYM NYSE
- Market Cap
- ESCA 193.7M
- CLYM 201.7M
- IPO Year
- ESCA N/A
- CLYM 2021
- Fundamental
- Price
- ESCA $14.53
- CLYM $2.14
- Analyst Decision
- ESCA
- CLYM
- Analyst Count
- ESCA 0
- CLYM 0
- Target Price
- ESCA N/A
- CLYM N/A
- AVG Volume (30 Days)
- ESCA 37.2K
- CLYM 187.2K
- Earning Date
- ESCA 10-24-2024
- CLYM 11-12-2024
- Dividend Yield
- ESCA 3.90%
- CLYM N/A
- EPS Growth
- ESCA 35.81
- CLYM N/A
- EPS
- ESCA 0.94
- CLYM N/A
- Revenue
- ESCA $253,074,000.00
- CLYM N/A
- Revenue This Year
- ESCA N/A
- CLYM N/A
- Revenue Next Year
- ESCA N/A
- CLYM N/A
- P/E Ratio
- ESCA $16.20
- CLYM N/A
- Revenue Growth
- ESCA N/A
- CLYM N/A
- 52 Week Low
- ESCA $12.34
- CLYM $2.02
- 52 Week High
- ESCA $22.01
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- ESCA 43.95
- CLYM N/A
- Support Level
- ESCA $14.63
- CLYM N/A
- Resistance Level
- ESCA $15.36
- CLYM N/A
- Average True Range (ATR)
- ESCA 0.70
- CLYM 0.00
- MACD
- ESCA -0.16
- CLYM 0.00
- Stochastic Oscillator
- ESCA 1.99
- CLYM 0.00
About ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.